Kedrion Biopharma celebrates World Hemophilia Day 2018
Support for patients with coagulation disorders worldwide is confirmed
50-Year Anniversary of a Maternal Health Breakthrough
Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai
Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017
The prize is awarded to the companies that made the best use of the capital markets
Kedrion Biopharma joins Columbia University to celebrate 50 years of Anti-D
Since 1968, billions of babies have been saved from Hemolytic Disease of the Fetus and Newborn
Hemophilia: Kedrion signs on to groundbreaking PARTNERS programme
Goal is to improve access to replacement therapies for coagulation disorders in Europe
Kedrion Biopharma joins IPOPI in supporting patients with APP PID Genius
This new APP, presented at the IPIC Congress in Dubai, will be the personal assistant to people living with PIDs
Kedrion and Cerus enter distribution agreement for INTERCEPT in Italy
Agreement covers complete INTERCEPT product line: platelets, plasma and red blood cells
Kedrion Biopharma and Kamada Ltd Receive FDA Approval for KEDRAB®
The product is approved for post-exposure prophylaxis against rabies infection
Kedrion Biopharma attends XXVI ISTH Congress in Berlin, Germany
A crowded symposium dedicated to the SIPPET Study was held on July 9th
Farmindustria roadshow is hosted by Kedrion
Innovation and Production of Value held on 19th May at our Bolognana production plant